Wednesday, October 4, 2023
Wednesday, October 4, 2023

Contact: 561.316.3330

TTG Imaging Solutions Reports Executive Leadership Changes

TTG Imaging Solutions announced today executive leadership changes that will drive the company’s next phase of growth following its 9th acquisition in 2 years of Medical Imaging Technologies, an Akron, Ohio based nuclear medicine equipment and service organization. The organization brought a robust customer base in the mid-west along with a strong group of field service engineers.

The following executive leadership changes are effective November 1, 2021:

  • Jack Tomayko, Ph.D., President & CEO, named Chairman
  • Matt Mastarone, Executive VP & Chief Financial Officer, named President & CEO
  • Mike Hewitt, Chief Business Development Officer, named Chief Operating Officer
  • Michelle Schweitzer, Vice President & Corporate Controller, named Chief Financial Officer

With strong leadership in new and existing roles TTG will continue to focus on further developing its nationwide footprint that supports nuclear and molecular diagnostic imaging equipment sales, service, repair, refurbishment, and installation coupled with radiopharmacy offerings and turnkey solutions.

Remaining in their current roles are John Nalley, EVP of Equipment Service Operations, and Hunter Forestier, VP of Sales and Marketing. John has oversight and responsibility for all aspects of TTG’s ISO certified equipment, service, and parts operations.  Hunter has responsibility for overseeing a dynamic group of sales professionals who are engaged in selling TTG’s portfolio of End-to End Solutions in the nuclear medicine and molecular imaging marketplace.

“These changes will help steer TTG into a new era where it can maximize the End-to-End Solution and differentiated service model,” says Jack Tomayko, Ph.D.

The TTG End-to End Solution is comprised of:

  • TTG Imaging Solutions – new and refurbished equipment sales, clinical applications support, parts, and nationwide service that help the marketplace extend the useful life of their valuable medical imaging equipment
  • Cardiac Imaging Solutions – turnkey nuclear, echo, and vascular testing programs that offer physician practices and health systems alike the flexibility and efficiency of an outsourced model
  • TTG Isotopes – radiopharmaceuticals that include cardiac imaging agents, custom-compounded iodine therapy, and a complete of line of products used in general imaging
Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.


Broken String Biosciences Strengthens Senior Leadership Team

Bringing significant expertise in their respective fields, Vincent Smith, PhD and Jessica Rich appointments are a key part of Broken String’s strategy to deliver on its Series A goals, which include the continued development of its INDUCE-seq™ DNA break-mapping platform and acceleration of its commercial expansion across global markets.

New Chief Sales Officer at Encare with Focus on Continued Global Expansion

The HealthTech company Encare has recruited Lotta Sellén as the new Chief Sales Officer (CSO). Lotta Sellén has solid experience in the pharmaceutical, healthcare and HealthTech industries.

CorWave Appoints Magalie Durrèche as Chief Financial Officer

Magalie Durrèche will oversee the financial management and participate in the strategic planning and fundraising of CorWave, a company developing and manufacturing a blood pump based on breakthrough technology. She succeeds Zina Hamoumi, who served as Chief Financial Officer for five years before deciding to focus on other projects.

Veracyte Names Dr Phillip G Febbo Chief Scientific Officer and Chief Medical Officer

“Phil G Febbo is an exceptional leader with a strong track record of driving successful commercialization of molecular tests through evidence development, guideline inclusion and key opinion leader support,” said Mr. Stapley. “His experience and expertise will be critical to further enhancing our ability to serve our customers and, ultimately, to transforming cancer care for patients all over the world.”

GrayMatters Health Expands US Executive Team, Including Appointment of Dr Aron Tendler as Chief Medical Office

Dr Aaron Tendler is a board-certified psychiatrist based in Palm Beach, Florida, bringing over 20 years of experience as an industry leader researching novel treatments for mental health disorders.

By using this website you agree to accept Medical Device News Magazine Privacy Policy